Renal Dialysis Market Size To Expand at a Notable CAGR Of 7.1% During 2017 - 2023 :

Pune, India, January 2019/MRFR Press Release/- Market Research Future has published a half-cooked research report on the Global Renal Dialysis Market.

Market Analysis

Renal dialysis market is likely to touch USD 26.6 Billion at an impelling 7.1% CAGR during the assessment period (2017-2023). Dialysis has turned into a key growth field as different forms of kidney diseases especially diabetes has exploded. Diabetes is the seventh leading cause of death. Dialysis is a means of removing waste products such as creatinine and urea from the blood owing to inappropriate kidney functioning and generally needed for those with chronic renal failure. This process is used for purifying the blood, removing excess toxins and fluid and restoring the electrolyte balance in the blood.

There are many factors that can be linked to the growth of renal dialysis market. Some of the market trends and factors in this market as per an analysis conducted by Market Research Future (MRFR) include increase in diabetes rate, large patient base of renal dialysis, lack of donors for kidney transplant, evolution of dialysis technology, overall growth of the healthcare sector, advances in renal dialysis equipment procedures and increasing number of patient suffering from hypertension and diabetes. On the flip side, there are a couple of factors that is likely to restrict the growth of the renal dialysis market such as high prices related to dialysis, complications post treatment, fall in Medicare reimbursements, manufacturers having pricing pressure from the government, product recalls, low awareness regarding kidney disease treatment modalities and reuse of the hemodialysis consumables.

Market Segmentation

Market Research Future report provides a comprehensive segmental analysis of the renal dialysis market on the basis of types, product and end user.

Based on type, it is segmented into primary and secondary dialysis. Primary dialysis is further segmented into peritoneal dialysis, hemofiltration and hemodialysis and secondary dialysis is further segmented into intestinal dialysis and hemodiafiltration.

Based on product, the renal dialysis market is segmented into peritoneal dialysis products and hemodialysis products. Of these, the hemodialysis products grab a higher market share.

Based on end user, it is segmented into home care and hospital care. Of these, home care has a higher share in the renal dialysis market.

Regional Analysis

Based on region, the renal dialysis market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Middle East and Africa. Of these, North America leads the renal dialysis market due to rising presence of large patient base having renal diseases in this region. Europe and Asia Pacific have similar market share but the APAC market is likely to grow relatively higher during the forecast period. The Middle East and African market possess a minimal share in the renal dialysis market and is predicted in exhibiting a limited growth during the forecast period.

Competitive Analysis

The renal dialysis market is extremely fragmented and based on clinical results of products and new product launches. Thus, the key players are using different strategies such as acquisitions, partnerships, joint ventures, agreements, high expense on R & D, market initiatives, clinical trials and new product launches.

Key Players

Leading players profiled in the renal dialysis market include NxStage Medical, Inc. (U.S.), Asahi Kasei Corporation (Japan), Nikkiso Co. Ltd. (Japan), Covidien (Ireland), Covidien (Ireland), Diaverum Deutschland GmbH (Germany), Nipro diagnostic Inc. (US), Nipro diagnostic Inc. (US), Gambro AB (Sweden), Medical Care AG & Co.,), B.Braun Melsungen AG (Germany), DaVita Healthcare Partners Inc. (US), Fresenius Medical Care (German) and Baxter International Inc. (US).

August 2018- A leading dialysis center network along with a pioneer in dialysis care, NephroPlus has launched unique buttonhole needles that will offer painless dialysis. This first of a kind buttonhole needles will use annulation method where the needles used will be blunt rather than sharp which in turn will drastically reduce the pain.

October 2018- ASN (American Society of Nephrology) and the US Department of HHS (Health and Human Services) have jointly announced to commit $2.6 million as prize money for a nationwide competition for accelerating innovation in kidney failure treatment. The competition called the KidneyX: Redesign Dialysis will challenge the public in developing improved treatment choices for kidney failure patients. They are on the lookout for innovators that can use scientific advancements and new technologies for disrupting and improving the manner in which patients with kidney failure are treated.

Browse Complete Report @